Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.515
+0.215 (6.52%)
At close: Apr 28, 2026, 4:00 PM EDT
3.520
+0.005 (0.14%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Alvotech Employees
Alvotech had 1,279 employees as of December 31, 2025. The number of employees increased by 267 or 26.38% compared to the previous year.
Employees
1,279
Change (1Y)
267
Growth (1Y)
26.38%
Revenue / Employee
$460,441
Profits / Employee
$21,829
Market Cap
1.10B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,279 | 267 | 26.38% |
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Evotec SE | 4,467 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Collegium Pharmaceutical | 423 |
ALVO News
- 4 days ago - Alvotech to Report Financial Results for the First Quarter of 2026 - GlobeNewsWire
- 4 weeks ago - Alvotech files Annual Report with the SEC - GlobeNewsWire
- 4 weeks ago - Alvotech Publishes 2025 Annual Report - GlobeNewsWire
- 5 weeks ago - Alvotech Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Alvotech Q4 2025 and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Alvotech Announces Increase in Number of Own Shares - GlobeNewsWire
- 2 months ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire